These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 7669559)

  • 21. Evidence for functional discrimination between leukemic cells overexpressing multidrug-resistance associated protein and P-glycoprotein.
    Benderra Z; Morjani H; Trussardi A; Manfait M
    Adv Exp Med Biol; 1999; 457():151-60. PubMed ID: 10500790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of H+-ATPase-dependent activity of multidrug resistance-associated protein in homoharringtonine-resistant human leukemic K562 cells.
    Benderra Z; Morjani H; Trussardi A; Manfait M
    Leukemia; 1998 Oct; 12(10):1539-44. PubMed ID: 9766497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flow cytometry evaluation of the multidrug-resistant phenotype with functional tests involving uptake of daunorubicin, Hoechst 33342, or rhodamine 123: a comparative study.
    Lizard G; Roignot P; Maynadie M; Lizard-Nacol S; Poupon MF; Bordes M
    Cancer Detect Prev; 1995; 19(6):527-34. PubMed ID: 8925522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility of idarubicin, daunorubicin, and their C-13 alcohol metabolites to transport-mediated multidrug resistance.
    Ross DD; Doyle LA; Yang W; Tong Y; Cornblatt B
    Biochem Pharmacol; 1995 Nov; 50(10):1673-83. PubMed ID: 7503771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein kinase C isoenzymes, p53, accumulation of rhodamine 123, glutathione-S-transferase, topoisomerase II and MRP in multidrug resistant cell lines.
    Utz I; Gekeler V; Ise W; Beck J; Spitaler M; Grunicke H; Hofmann J
    Anticancer Res; 1996; 16(1):289-96. PubMed ID: 8615623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells.
    Eijdems EW; Zaman GJ; de Haas M; Versantvoort CH; Flens MJ; Scheper RJ; Kamst E; Borst P; Baas F
    Br J Cancer; 1995 Aug; 72(2):298-306. PubMed ID: 7640209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring interactions at ATP-dependent drug efflux pumps.
    Hendrikse NH
    Curr Pharm Des; 2000 Nov; 6(16):1653-68. PubMed ID: 10974159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between cytotoxic drug response patterns and activity of drug efflux transporters mediating multidrug resistance.
    Dhar S; Nygren P; Liminga G; Sundström C; de la Torre M; Nilsson K; Larsson R
    Eur J Pharmacol; 1998 Apr; 346(2-3):315-22. PubMed ID: 9652375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of the ABC transporter TAP in multidrug-resistant human cancer cell lines.
    Izquierdo MA; Neefjes JJ; Mathari AE; Flens MJ; Scheffer GL; Scheper RJ
    Br J Cancer; 1996 Dec; 74(12):1961-7. PubMed ID: 8980397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of multidrug resistance in drug-resistant human gastric cancer cell line SGC7901/VCR by antiprogestin drug mifepristone.
    Li DQ; Wang ZB; Bai J; Zhao J; Wang Y; Hu K; Du YH
    World J Gastroenterol; 2004 Jun; 10(12):1722-5. PubMed ID: 15188493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia.
    Tsimberidou AM; Paterakis G; Androutsos G; Anagnostopoulos N; Galanopoulos A; Kalmantis T; Meletis J; Rombos Y; Sagriotis A; Symeonidis A; Tiniakou M; Zoumbos N; Yataganas X
    Leuk Res; 2002 Feb; 26(2):143-54. PubMed ID: 11755464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia.
    van der Kolk DM; de Vries EG; van Putten WJ; Verdonck LF; Ossenkoppele GJ; Verhoef GE; Vellenga E
    Clin Cancer Res; 2000 Aug; 6(8):3205-14. PubMed ID: 10955805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ATP-dependent efflux of calcein by the multidrug resistance protein (MRP): no inhibition by intracellular glutathione depletion.
    Feller N; Broxterman HJ; Währer DC; Pinedo HM
    FEBS Lett; 1995 Jul; 368(2):385-8. PubMed ID: 7628644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of multidrug resistant phenotype by flow cytometry with monoclonal antibodies and functional tests.
    Lizard G; Maynadié M; Roignot P; Lizard-Nacol S; Poupon MF
    Bull Cancer; 1995 Mar; 82(3):211-7. PubMed ID: 7655150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells.
    Marbeuf-Gueye C; Broxterman HJ; Dubru F; Priebe W; Garnier-Suillerot A
    Mol Pharmacol; 1998 Jan; 53(1):141-7. PubMed ID: 9443942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multidrug resistance-modifying components in human plasma with potential clinical significance.
    Mülder HS; Pinedo HM; Timmer AT; Rao BR; Lankelma J
    J Exp Ther Oncol; 1996 Jan; 1(1):13-22. PubMed ID: 9414384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of drug accumulation in P-glycoprotein-expressing and MRP-expressing human leukaemia cells.
    Davey MW; Hargrave RM; Davey RA
    Leuk Res; 1996 Aug; 20(8):657-64. PubMed ID: 8913319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transport properties of the multidrug resistance-associated protein (MRP) in human tumour cells.
    Holló Z; Homolya L; Hegedüs T; Sarkadi B
    FEBS Lett; 1996 Mar; 383(1-2):99-104. PubMed ID: 8612802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subcellular daunorubicin distribution and its relation to multidrug resistance phenotype in drug-resistant cell line SMMC-7721/R.
    Yang JY; Luo HY; Lin QY; Liu ZM; Yan LN; Lin P; Zhang J; Lei S
    World J Gastroenterol; 2002 Aug; 8(4):644-9. PubMed ID: 12174371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple gene expression analysis reveals distinct differences between G2 and G3 stage breast cancers, and correlations of PKC eta with MDR1, MRP and LRP gene expression.
    Beck J; Bohnet B; Brügger D; Bader P; Dietl J; Scheper RJ; Kandolf R; Liu C; Niethammer D; Gekeler V
    Br J Cancer; 1998; 77(1):87-91. PubMed ID: 9459150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.